Startups

Neuralink

Fremont, California · Fremont, California, United States

neuralink.com

en.wikipedia.org

flickr.com

Private neurotechnology company developing the investigational N1 neural implant and R1 surgical robot. SEC principal business address is Fremont; Austin operations do not establish headquarters. Current CEO title remains qualified.

Founded 2016

Team

David McMullenMedical Affairs leadership appointment December2025

Dongjin SeoCo-founder, President and COO

Elon MuskCo-founder

Jared BirchallOfficer / director; Secretary

Investments

$650M2025-06-02	GV, Founders Fund, DFJ Growth, ARK, Vy Capital, G42, Human Capital, Lightspeed Venture Partners, Qatar Investment Authority, Sequoia Capital, Thrive Capital, Valor Equity Partners
$280M2023-08-07	Founders Fund
$205M2021-07-29	Vy Capital, Founders Fund, DFJ Growth, GV, Time BioVentures, Craft Ventures, Valor Equity Partners, Gigafund, Robert Nelsen, Blake Byers, Sam Altman, Fred Ehrsam, Ken Howery
$26M2017-08-25	0 participations

team@apexlogos.ai11 minutes ago
Funding cleanup, reviewed 2026-10-06: former record 26109 was portfolio evidence or prospective fundraising coverage, not a separately established closed financing. Investors previously associated: FutureVentures. Recorded date: unknown; amount: unknown. Source: https://future.ventures/investments/. Original evidence: Public firm investment claim researched 2026-09-14. Firm claim source: https://future.ventures/investments/. Company: Neuralink; stage: unknown; date: unknown.. Confirmed Series E participants remain on the June 2, 2025 $650M financing. A portfolio listing alone does not establish another funding event. Additional source evidence: [{"sourceUrl":"https://future.ventures/investments/","evidence":"Public firm investment claim researched 2026-09-14. Firm claim source: https://future.ventures/investments/. Company: Neuralink; stage: unknown; date: unknown.","verifiedAt":null,"additionalMetadata":[]}]
team@apexlogos.ai11 minutes ago
Funding cleanup, reviewed 2026-10-06: former record 19812 was portfolio evidence or prospective fundraising coverage, not a separately established closed financing. Investors previously associated: HumanCapital. Recorded date: unknown; amount: unknown. Source: https://human.capital/portfolio. Original evidence: none. Confirmed Series E participants remain on the June 2, 2025 $650M financing. A portfolio listing alone does not establish another funding event. Additional source evidence: [{"sourceUrl":"https://human.capital/portfolio","evidence":"Neuralink is listed on the firm's official portfolio.","verifiedAt":null,"additionalMetadata":[]}]
team@apexlogos.ai11 minutes ago
Funding cleanup, reviewed 2026-10-06: former record 13440 was portfolio evidence or prospective fundraising coverage, not a separately established closed financing. Investors previously associated: FoundersFund, ThriveCapital, SequoiaCapital, Sequoia. Recorded date: unknown; amount: unknown. Source: https://www.bloomberg.com/news/articles/2025-04-23/musk-s-neuralink-said-to-eye-fundraise-at-8-5-billion-valuation. Original evidence: none. Confirmed Series E participants remain on the June 2, 2025 $650M financing. A portfolio listing alone does not establish another funding event. Additional source evidence: [{"sourceUrl":"https://goldi.ai/intelligence/vc/founders-fund","evidence":"Goldilocks public investor intelligence; source claims retained in GoldilocksProfile/Deal/Team.","verifiedAt":null,"additionalMetadata":[]},{"sourceUrl":"https://goldi.ai/intelligence/vc/sequoia-capital","evidence":"Goldilocks public investor intelligence; source claims retained in GoldilocksProfile/Deal/Team.","verifiedAt":null,"additionalMetadata":[]}]
team@apexlogos.ai11 minutes ago
Funding cleanup, reviewed 2026-10-06: former record 11048 was portfolio evidence or prospective fundraising coverage, not a separately established closed financing. Investors previously associated: Lightspeed. Recorded date: 2025; amount: unknown. Source: https://lsvp.com/companies/. Original evidence: Lightspeed’s official portfolio profile lists Neuralink as backed since 2025 with status Private. Lightspeed official portfolio relationship for Neuralink; earliest publicly supported investment date: 2025. Portfolio status: Private. Official attribution: LSVP.. Confirmed Series E participants remain on the June 2, 2025 $650M financing. A portfolio listing alone does not establish another funding event. Additional source evidence: [{"sourceUrl":"https://lsvp.com/companies/","evidence":"Lightspeed’s official portfolio profile lists Neuralink as backed since 2025 with status Private. Lightspeed official portfolio relationship for Neuralink; earliest publicly supported investment date: 2025. Portfolio status: Private. Official attribution: LSVP.","verifiedAt":null,"additionalMetadata":[]},{"sourceUrl":"https://lsvp.com/company/neuralink/","evidence":"Lightspeed’s official portfolio profile lists Neuralink as backed since 2025 with status Private. Lightspeed official portfolio relationship for Neuralink; earliest publicly supported investment date: 2025. Portfolio status: Private. Official attribution: LSVP.","verifiedAt":null,"additionalMetadata":[]}]
team@apexlogos.ai40 minutes ago
BCI research snapshot, reviewed 2026-10-06. Company identity: Neuralink. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts. Part 1/1 # Neuralink Research date: **2026-10-06**. Review material only; no adex data was modified. All linked sources and HTML image references were accessed on this date. ## Identity and operating status **Neuralink Corp.**, privately held neurotechnology corporation. SEC2025 FormD identifies Nevada incorporation and **7400 Paseo Padre Parkway, Fremont, California** principal place of business; pasted Austin is not supported as corporate HQ by this filing. [2017 SEC issuer filing](https://www.sec.gov/Archives/edgar/data/1708503/000170850317000001/xslFormDX01/primary_doc.xml) confirms incorporation in **2016**, then Delaware (later filing Nevada). [SEC issuer filing](https://www.sec.gov/Archives/edgar/data/1708503/000170850325000003/xslFormDX01/primary_doc.xml) Develops **N1/Link implant and R1 surgical robot**, studied under investigational clinical protocols. Active research/clinical operations are supported by [official site](https://neuralink.com/). An investigational authorization or breakthrough designation does not establish commercial approval. ## Audit of pasted BCI.INTEL entry | Pasted claim | Assessment | |---|---| | Austin HQ | Conflicts with SEC2025 principal business address Fremont; distinguish Texas operations/incorporation/address from HQ. | | Jared Birchall CEO | Not established. SEC identifies officer/director and signatory Secretary. Tesla biography explicitly calls Elon Musk Neuralink CEO, but page includes older text; company should confirm current executive titles. | | Elon co-founder/chairman | Founding relationship credible; precise current chairman role not established by examined issuer filing. | | $1.3B+ | Plausible historical aggregate but not reconciled here; retain sourced individual transactions. | | N1; active | Genuine investigational product, current clinical development. | ## Company profile image Direct company social/profile asset: [Official default share PNG](https://neuralink.com/assets/static/default.Cp3rD03M.png). Homepage OG banner: [JPEG](https://neuralink.com/assets/static/homepage.CQ861ZM0.jpg). Extracted from official live HTML; banner is not necessarily a square logo. Most current named leadership pages do not expose a verified direct portrait; absent images are explicitly held. ## Founders and public team | Person | Role / relationship | Profile and role evidence | Direct profile image URL | |---|---|---|---| | Elon Musk | Co-founder; Tesla biography calls Neuralink CEO; SEC officer | [Role/profile source](https://www.tesla.com/elon-musk) | Unavailable; examined cited official/institutional profile; no named portrait URL verified | | Jared Birchall | SEC2025 officer/director; signed as Secretary, not proof of CEO | [Role/profile source](https://www.sec.gov/Archives/edgar/data/1708503/000170850325000003/xslFormDX01/primary_doc.xml) | Unavailable; examined cited official/institutional profile; no named portrait URL verified | | David McMullen | Medical Affairs leadership appointment December2025 | [Role/profile source](https://neuralink.com/updates/welcome-david-mcmullen/) | Unavailable; examined cited official/institutional profile; no named portrait URL verified | | Max Hodak | Former Neuralink co-founder, now Science CEO | [Role/profile source](https://www.xprize.org/people/max-hodak) | [PFP](https://assets-us-01.kc-usercontent.com:443/9bc15d1f-8a5c-007d-b507-e3496e85af86/38903e09-797d-4035-aa51-89146cb0fcf9/Max%20Hodak.webp) | Neuralink has no full named current executive gallery in examined official pages. Historical co-founder lists include Benjamin Rapoport, Dongjin Seo, Paul Merolla, Philip Sabes, Tim Gardner, Tim Hanson and Vanessa Tolosa; do not import all as current team or establish titles from unsourced lists. [Historical founder research/biography context](https://www.precisionneuro.io/our-vision) confirms former Neuralink associations for relevant Precision leaders; their current employer is Precision. No guessed social-photo URLs were supplied. ## Investments and financing | Announced | Round | USD amount | Lead / named investors | Evidence | |---|---|---:|---|---| | 2017-08-25 filing; firstsale2017-08-15 | Equity offering; no sourced round label | $26,958,000 sold at filing date | 12 unnamed investors; **$100,155,000 target is not amount raised** | [SEC FormD](https://www.sec.gov/Archives/edgar/data/1708503/000170850317000001/xslFormDX01/primary_doc.xml) | | 2021-07-29 | Series C | $205M | Led Vy Capital; GV/Google Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures, Founders Fund, Gigafund; individuals Robert Nelson, Blake Byers, Sam Altman, Fred Ehrsam, Ken Howery | [Official announcement](https://neuralink.com/updates/series-c-funding-round-announcement/) | | 2023-08-07 | Series D | $280M | Led Founders Fund; complete participant set not disclosed in short company announcement | [Official announcement](https://neuralink.com/updates/neuralink-raises-280m-series-d/) | | 2025-06-02 | Series E | $650M rounded announcement | ARK Invest; DFJ Growth; Founders Fund; G42; Human Capital; Lightspeed; QIA; Sequoia Capital; Thrive Capital; Valor Equity Partners; Vy Capital; lead not specified | [Official announcement](https://neuralink.com/updates/neuralink-raises-650m-series-e/) | 2025SEC filing records **$649,000,093 sold**, first sale2025-05-30,49investors. This is filing-level precision supporting the rounded SeriesE announcement, **not a second round**. [FormD](https://www.sec.gov/Archives/edgar/data/1708503/000170850325000003/xslFormDX01/primary_doc.xml) Earlier equity and reported2023extension need original filings/release reconciliation before asserting a lifetime aggregate; listed headline rounds sum$1.135B. No verified grant/debt/acquisition close added in this review. No funding target is treated as proceeds received. ## Existing adex match and review decision Existing `Neuralink`; update evidence and preserve existing ID. Review HQ and executive-role corrections carefully. Do not assert Jared CEO or current founder membership solely from pasted table. Read-only `Org` lookup found the following records. The snapshot below records existing claims, **not verification of those claims**.
team@apexlogos.ai21 days ago
COMPETITION